Herliawati, P.A. , Harnandari, D.E.P. , Hildayanti, R.A. , Wicaksana, A. and Firsta, P.P. 2023. Malignancy Risk Index 4 (RMI 4) is better than RMI 3 as a predictor Advanced Epithelial Ovarian Carcinoma was used for NACT. Jurnal Ners. 7, 1 (Apr. 2023), 536–542. DOI:https://doi.org/10.31004/jn.v7i1.13495.